Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma

References

• Snow H. Melanotic cancerous disease. Lancet2, 872 (1892).
   Google Scholar
• Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann. Surg.193(3), 377–388 (1981).
   PubMed Web of Science ®Google Scholar
• Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann. Surg.214(4), 491–501 (1991).
   PubMed Web of Science ®Google Scholar
• McCarthy WH, Shaw HM, Milton GW. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg. Gynecol. Obstet.161(6), 575–580 (1985).
   PubMedGoogle Scholar
• Reintgen DS, Cox EB, McCarty KS Jr, Vollmer RT, Seigler HF. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann. Surg.198(3), 379–385 (1983).
   PubMed Web of Science ®Google Scholar
• Roses DF, Provet JA, Harris MN, Gumport SL, Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann. Surg.201(1), 103–107 (1985).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery86(2), 343–351 (1979).
   PubMed Web of Science ®Google Scholar
• Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J. Clin. Oncol.6(1), 163–172 (1988).
   PubMed Web of Science ®Google Scholar
• Milton GW, Shaw HM, McCarthy WH, Pearson L, Balch CM, Soong SJ. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br. J. Surg.69(2), 108–111 (1982).
   PubMed Web of Science ®Google Scholar
• Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer41(3), 948–956 (1978).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Adamus J, Bandiera DC et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N. Engl. J. Med.297(12), 627–630 (1977).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Adamus J, Bandiera DC et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer49(11), 2420–2430 (1982).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann. Surg.224(3), 255–266 (1996).
   PubMed Web of Science ®Google Scholar
• Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg.127(4), 392–399 (1992).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Morton DL. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J. Surg.16(2), 214–221 (1992).
   PubMed Web of Science ®Google Scholar
• Thompson JF, McCarthy WH, Bosch CM et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res.5(4), 255–260 (1995).
   PubMed Web of Science ®Google Scholar
• Leong SP, Steinmetz I, Habib FA et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch. Surg.132(6), 666–673 (1997).
   PubMedGoogle Scholar
• Morton DL, Thompson JF, Essner R et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann. Surg.230(4), 453–465 (1999).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Milton GW et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann. Surg.196(6), 677–684 (1982).
   PubMed Web of Science ®Google Scholar
• Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon α-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J. Clin. Oncol.14(1), 7–17 (1996).
   PubMed Web of Science ®Google Scholar
• Kelley MC, Ollila DW, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin. Surg. Oncol.14(4), 283–290 (1998).
   PubMedGoogle Scholar
• Robinson DS, Sample WF, Fee HJ, Holmes C, Morton DL. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg. Forum28, 147–148 (1977).
   PubMedGoogle Scholar
• Yee VS, Thompson JF, McKinnon JG et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann. Surg. Oncol.12, 429–439 (2005).
   PubMed Web of Science ®Google Scholar
• Nowecki ZI, Rutlowski P, Nasierowska-Guttmejer A, Ruka W. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institutions experience. Melanoma Res.13, 35–43 (2003).
   PubMed Web of Science ®Google Scholar
• Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J. Nucl. Med.39(7), 1185–1190 (1998).
   PubMed Web of Science ®Google Scholar
• Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin. Oncol.24(1 Suppl. 4), S8–S10 (1997).
   Web of Science ®Google Scholar
• Glass EC, Basinski JE, Krasne DL, Giuliano AE. Radiation safety considerations for sentinel node techniques. Ann. Surg. Oncol.6(1), 10–11 (1999).
   PubMed Web of Science ®Google Scholar
• Essner R, Foshag L, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. The Annual Meeting of the Society of Surgical Oncologists. TX, USA, 17 March 1994.
   Google Scholar
• Bostick P, Essner R, Glass E et al. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch. Surg.134(1), 43–49 (1999).
   PubMedGoogle Scholar
• Essner R, Bostick PJ, Glass EC et al. Standardized probe-directed sentinel node dissection in melanoma. Surgery127(1), 26–31 (2000).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am. J. Surg. Pathol.12(8), 612–618 (1988).
   PubMed Web of Science ®Google Scholar
• Essner R, Cochran AJ. Sentinel node biopsy: not only a staging tool? Recent Results Cancer Res.160, 133–148 (2002).
   PubMedGoogle Scholar
• Carson KF, Wen DR, Li PX et al. Nodal nevi and cutaneous melanomas. Am. J. Surg. Pathol.20(7), 834–840 (1996).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Herschman HR, Gaynor RB. Detection of S-100 protein as an aid to the identification of melanocytic tumors. Int. J. Cancer30(3), 295–297 (1982).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Bailly C, Paul E, Remotti F. Melanotic Tumors: A Guide To Diagnosis. Lippincott–Raven, PA, USA (1997).
   Google Scholar
• Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol.22, 3345–3349 (2004).
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Wen DR, Huang RR et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and sentinel node. Mod. Pathol.17, 747–755 (2004).
   PubMed Web of Science ®Google Scholar
• Starz H, De Donno A, Balda B. The Augsberg experience: histological aspects and patient outcomes. Ann. Surg. Oncol.8(Suppl. 9), 48–51 (2001).
   Google Scholar
• Heller R, Becker J, Wasselle J et al. Detection of submicroscopic lymph node metastases in patients with melanoma. Arch. Surg.126(12), 1455–1460 (1991).
   PubMedGoogle Scholar
• Reintgen D, Balch CM, Kirkwood J, Ross M. Recent advances in the care of the patient with malignant melanoma. Ann. Surg.225(1), 1–14 (1997).
   PubMed Web of Science ®Google Scholar
• Kammula US, Ghossein R, Bhattacharya S, Coit DG. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients. J. Clin. Oncol.22(19), 3989–3996 (2004).
   PubMed Web of Science ®Google Scholar
• McMasters KM, Noyes RD, Reintgen DS et al. Lessons learned from the sunbelt melanoma trial. J. Surg. Oncol.86, 212–223 (2004).
   PubMed Web of Science ®Google Scholar
• Morton DL. Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? Cancer J. Sci. Am.3(6), 328–330 (1997).
   PubMed Web of Science ®Google Scholar
• Morton DL, Cochran AJ, Thompson JF et al. Sentinel node biopsy for early-stage melanoma accuracy and morbidity in MSLT-1, an international multicenter trial. Ann. Surg.242(3), 302–313 (2005).
   PubMed Web of Science ®Google Scholar
• Morton DL, Thompson JF, Cochran AJ et al. ASCO annual meeting proceedings. J. Clin.Oncol.23, (16 Suppl. Part I of II) (2005).
   Google Scholar
• Shivers SC, Wang X, Li W et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA280(16), 1410–1415 (1998).
   PubMed Web of Science ®Google Scholar